Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$27.76
0.732.70%
Last update: 12:47 PM
Comments
Loading...
RAPT Therapeutics (RAPT) Forecast
NewsEarningsOptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestStock ReportEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
RAPT Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RAPT | Benzinga
Explore RAPT Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RAPT.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy RAPT Therapeutics (RAPT) stock?
You can purchase shares of RAPT Therapeutics (NASDAQ:RAPT) through any online brokerage.
Who are RAPT Therapeutics (RAPT) competitors?
Other companies in RAPT Therapeutics’s space includes: Bright Minds Biosciences (NASDAQ:DRUG), 4D Molecular Therapeutics (NASDAQ:FDMT), Korro Bio (NASDAQ:KRRO), Immuneering (NASDAQ:IMRX) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for RAPT Therapeutics (RAPT) stock?
RAPT Therapeutics has a consensus price target of $26.71.
What is the current price for RAPT Therapeutics (RAPT)?
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $27.76 last updated October 16, 2025 at 12:47 PM EDT.
Does RAPT Therapeutics (RAPT) pay a dividend?
There are no upcoming dividends for RAPT Therapeutics.
When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?
RAPT Therapeutics’s Q3 earnings are confirmed for Tuesday, November 11, 2025.
Is RAPT Therapeutics (RAPT) going to split?
There is no upcoming split for RAPT Therapeutics.
What sector and industry does RAPT Therapeutics (RAPT) operate in?
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
